Newly approved pancreatic cancer drug shows promise in lung cancer

In an early clinical trial, one-third of patients with advanced lung cancer saw their tumors shrink. Larger trials are underway.

A groundbreaking pancreatic cancer drug shows promise against the most common form of lung cancer, according to clinical trial results published Wednesday in the New England Journal of Medicine.

Just a moment.

We are getting your experience ready.